{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:03Z","timestamp":1791919983382,"version":"4.3.4"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Psoriasis is an immune-mediated, persistent inflammatory disease with a genetic predisposition, and the involvement of multiple organs in psoriasis remains indicative of systemic disease. Atherosclerosis (AS) is a common complication of patients with severe or prolonged psoriasis. The specific pathogenesis of psoriasis is still unclear. Current studies suggest that psoriasis is a polygenic genetic disease with the interaction of multiple factors such as heredity and environment. Keratinocytes are proliferated through immune-mediated inflammatory pathway, which leads to cell activation, infiltration of dermis cells and release of inflammatory factors. Activation of inflammatory cells and pro-inflammatory factors play an important role in the progression of psoriasis and atherosclerosis. Studies have found that there is a close relationship between psoriasis and atherosclerosis, and systemic inflammation may be the common feature of psoriasis and AS. This paper attempts to explore the possibility of the relationship between psoriasis and atherosclerotic comorbidities from the aspects of potential epidemiology and immune mechanism, in order to provide some reference for the subsequent scientific research.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1070750","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T08:10:20Z","timestamp":1671091820000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Immunity: Psoriasis comorbid with atherosclerosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Chunping","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiding","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sien","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B2","volume-title":"Global report on psoriasis","year":"2016"},{"key":"B3","unstructured":"Come together for world psoriasis day2020"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15610","article-title":"The global state of psoriasis disease epidemiology: a workshop report","volume":"177","author":"Griffiths","year":"2017","journal-title":"Br J Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"Jama"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01668","article-title":"Psoriasis, cardiovascular events, and biologics: Lights and shadows","volume":"9","author":"Caiazzo","year":"2018","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313816","article-title":"Atherosclerosis","volume":"123","author":"Kobiyama","year":"2018","journal-title":"Circ Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.030484","article-title":"Inflammation and atherosclerosis: The end of a controversy","volume":"136","author":"Hansson","year":"2017","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921(2","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14040758","article-title":"Designer functional nanomedicine for myocardial repair by regulating the inflammatory microenvironment","volume":"14","author":"Liu","year":"2022","journal-title":"Pharmaceutics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.758050","article-title":"Therapeutic applications of extracellular vesicles for myocardial repair","volume":"7","author":"Liu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cells11192972","article-title":"PCSK9 inhibition: from current advances to evolving future","volume":"11","author":"Liu","year":"2022","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jdv.12163","article-title":"Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review","author":"Horreau","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/1203475415602842","article-title":"Psoriasis as an independent risk factor for cardiovascular disease: An epidemiologic analysis using a national database","volume":"20","author":"Lai","year":"2016","journal-title":"J Cutan Med Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01234","article-title":"Potential immunological links between psoriasis and cardiovascular disease","volume":"9","author":"Sajja","year":"2018","journal-title":"Front Immunol"},{"key":"B18","article-title":"Psoriasis and cardiovascular disorders","volume":"151","author":"Frieder","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/0003319716652284","article-title":"Assessment of arterial stiffness in Korean patients with psoriasis by cardio-ankle vascular index","volume":"68","author":"Choi","year":"2017","journal-title":"Angiology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.12.015","article-title":"Impaired coronary flow reserve in young patients affected by severe psoriasis","volume":"221","author":"Osto","year":"2012","journal-title":"Atherosclerosis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07562.x","article-title":"Psoriasis: A possible risk factor for development of coronary artery calcification","volume":"156","author":"Ludwig","year":"2007","journal-title":"Br J Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3892\/etm.2022.11124","article-title":"Update on the etiopathogenesis of psoriasis (Review)","volume":"23","author":"Branisteanu","year":"2022","journal-title":"Exp Ther Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00139","article-title":"Immune-mediated inflammation promotes subclinical atherosclerosis in recent-onset psoriatic arthritis patients without conventional cardiovascular risk factors","volume":"9","author":"Kolliker Frers","year":"2018","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13420","article-title":"Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders","volume":"56","author":"Owczarczyk-Saczonek","year":"2017","journal-title":"Int J Dermatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03096","article-title":"IL-17A in psoriasis and beyond: Cardiovascular and metabolic implications","volume":"15","author":"von Stebut","year":"2020","journal-title":"Front Immunol Jan"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08780.x","article-title":"Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach","volume":"159","author":"Spah","year":"2008","journal-title":"Br J Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2009.01016.x","article-title":"Functional characterization of T cells differentiated in vitro from bone marrow-derived CD34 cells of psoriatic patients with family history","volume":"19","author":"Zhang","year":"2010","journal-title":"Exp Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.clim.2014.12.012","article-title":"Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and treg cells in patients with acute coronary syndrome","volume":"157","author":"Zheng","year":"2015","journal-title":"Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400181","article-title":"IL-17A influences essential functions of the monocyte\/macrophage lineage and is involved in advanced murine and human atherosclerosis","volume":"193","author":"Erbel","year":"2014","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs399","article-title":"Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown","volume":"34","author":"Liuzzo","year":"2013","journal-title":"Eur Heart J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/path.2667","article-title":"Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques","volume":"220","author":"de Boer","year":"2010","journal-title":"J Pathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.169","article-title":"Regulatory T cells in cardiovascular diseases","volume":"13","author":"Meng","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5114\/ada.2020.96085","article-title":"Cardiovascular risk in patients with plaque psoriasis and psoriatic arthritis without a clinically overt cardiovascular disease: the role of endothelial progenitor cells","volume":"37","author":"Michalska","year":"2020","journal-title":"Postepy Dermatol Alergol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2001310","article-title":"IFN-gamma drives human monocyte differentiation into highly proinflammatory macrophages that resemble a phenotype relevant to psoriasis","volume":"207","author":"Luque-Martin","year":"2021","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.91","article-title":"Macrophage heterogeneity in the context of rheumatoid arthritis","volume":"12","author":"Udalova","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75005","article-title":"Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression","volume":"127","author":"Rahman","year":"2017","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.839460","article-title":"Homogeneous polyporus polysaccharide inhibit bladder cancer by resetting tumor-associated macrophages toward m1 through nf-\u03bab\/nlrp3 signaling","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.05.062","article-title":"Engineered extracellular vesicles and their mimetics for cancer immunotherapy","volume":"349","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3523642","article-title":"Involvement of M1 macrophage polarization in endosomal toll-like receptors activated psoriatic inflammation","volume":"2018","author":"Lu","year":"2018","journal-title":"Mediators Inflammation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.cir.0000052939.59093.45","article-title":"Centers for disease, prevention, a. American heart, markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American heart association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.97179","article-title":"Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis","volume":"3","author":"Baumer","year":"2018","journal-title":"JCI Insight"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3233\/CH-131766","article-title":"Increased circulating endothelial cells and microparticles in patients with psoriasis","volume":"60","author":"Martinez-Sales","year":"2015","journal-title":"Clin Hemorheol Microcirc"},{"key":"B47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11883-020-00841-z","article-title":"Microparticles (Exosomes) and atherosclerosis","volume":"22","author":"Chen","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv339","article-title":"Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis","volume":"36","author":"Salahuddin","year":"2015","journal-title":"Eur Heart J"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.724670","article-title":"Danlou tablets inhibit atherosclerosis in apolipoprotein e-deficient mice by inducing macrophage autophagy: The role of the pi3k-akt-mtor pathway","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11883-017-0692-8","article-title":"Emerging associations between neutrophils, atherosclerosis, and psoriasis","volume":"19","author":"Sanda","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.257535","article-title":"Multiple roles for neutrophils in atherosclerosis","volume":"110","author":"Soehnlein","year":"2012","journal-title":"Circ Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-013-0375-7","article-title":"Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity","volume":"35","author":"Carmona-Rivera","year":"2013","journal-title":"Semin Immunopathol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.306460","article-title":"Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET\/CT and neutrophil activation in a prospective observational study","volume":"35","author":"Naik","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.303566","article-title":"Dendritic cells in atherosclerosis: evidence in mice and humans","volume":"35","author":"Zernecke","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/248317","article-title":"NK cells and psoriasis","volume":"2011","author":"Dunphy","year":"2011","journal-title":"J BioMed Biotechnol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.7.284","article-title":"Pathogenic mechanisms shared between psoriasis and cardiovascular disease","volume":"7","author":"Ghazizadeh","year":"2010","journal-title":"Int J Med Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1070750\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T08:10:25Z","timestamp":1671091825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1070750\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2022.1070750"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1070750","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"article-number":"1070750"}}